Sharemaestro company-news research for Zydus Lifesciences Limited (ZYDUSLIFE), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NSI
India
Measured evidence
Company news sentiment
ZYDUSLIFE news sentiment
Zydus Lifesciences Limited
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone49Neutral is 50
Balanced news tone
44/100 evidence confidence
100% direct company focus
1 current stories across 1 publishers
Checking for newer ZYDUSLIFE headlines
An earlier measured reading is retained below: 47/100 from 26 articles on 13 Aug 05:17. Current source headlines are being refreshed without delaying this page.
Current company news
Balanced read
Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.
Latest source headline Zydus Lifesciences reschedules Motilal Oswal investor conference to Aug 17 scanx.trade · 12 Aug 2026 17:13What supports the read
1 current stories are mapped specifically to ZYDUSLIFE.
What tempers the read
Only 1 publisher currently contribute to the measured read.
49/100
Weighted toneBalanced news tone
44/100
Evidence confidencebuilding confidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth12
1.0 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness90
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
News tone and price action are not far from neutral.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
News subjects
What is shaping the score
Market update471 stories · 100%
Source mix
Where the evidence comes from
scanx.trade471 stories · 100%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#147Tone
scanx.tradeDirect company coverage
Zydus Lifesciences reschedules Motilal Oswal investor conference to Aug 17
- Published
- 12 Aug 2026 17:13
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.